Linnet Akinyi

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury*

A. Gabrielli, C. Robertson, H. Hannay, 2010, Critical care medicine.

Ubiquitin C‐terminal hydrolase‐L1 as a biomarker for ischemic and traumatic brain injury in rats

F. Tortella, R. Hayes, J. Dave, 2010, The European journal of neuroscience.

Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

F. Tortella, C. Robertson, R. Hayes, 2012, Annals of emergency medicine.

Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

F. Tortella, C. Robertson, R. Hayes, 2012, The journal of trauma and acute care surgery.

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.

A. Gabrielli, C. Robertson, R. Hayes, 2010, Journal of neurotrauma.

Biochemical, Structural, and Biomarker Evidence for Calpain-Mediated Cytoskeletal Change After Diffuse Brain Injury Uncomplicated by Contusion

B. Kelley, R. Hayes, Kevin K. W. Wang, 2009, Journal of neuropathology and experimental neurology.